Summary: Lipocine Inc. , a clinical-stage biopharmaceutical company focused on developing innovative products for neuroendocrine and metabolic disorders, announced today that Antares…
Inc
-
-
RegulatoryU.S FDA
TherapeuticsMD Receives U.S. Receives US Food and Drug Administration (FDA) Approval for the Supplemental New Drug Application (sNDA) for ANNOVERA
by adminby adminSummary : ANNOVERA is the only FDA-approved procedure-free, long-lasting, reversible birth control – -With this approval, the Company expects a significant reduction…
-
Global MarketPharma Science & Research
SAB Biotherapeutics Announces Publication of Nonclinical Data Demonstrating SAB-185 Has High Potency for Effectively Neutralizing Circulating and Emerging SARS-CoV-2 Variants
by adminby adminSummary : – In the FDA-conducted study, SAB-185 consistently demonstrated high avidity and high potency for effectively neutralizing a broad range of…
-
CompaniesGlobal MarketNovartis
Syncona announces sale of portfolio company to Novartis
by adminby adminSynopsis : Syncona – a company focused on founding, building and funding global leaders in life science – has announced the sale…
-
Pharma Science & Research
Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
by adminby adminSummary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease…
-
Global MarketPharma Science & Research
AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma
by adminby adminSummary- Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience long-term PFS compared to Nexavar® (sorafenib)…
-
Agrochemicals
Home BancShares, Inc. Enhances Marine Segment Through Portfolio Acquisition
by adminby adminSummary : Home BancShares, Inc. (NYSE: HOMB) (“Home” or the “Company”), parent company of Centennial Bank, (“Centennial”), today announced that it has…
-
AgrochemicalsGlobal Market
Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies
by adminby adminSummary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel…
-
AgrochemicalsIndia
Ocugen, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
by adminby adminSynopsis : Company announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase…
-
Global Market
Ardelyx Reports Additive Positive Data Supporting Clinical Utility of Tenapanor at ASN’s Kidney Week 2021
by adminby adminKey Point – First patient reported outcome data on Tenapanor from OPTIMIZE trial demonstrates improved overall patient experience and benefit of one…